Sergio Baranzini, PhD
Sergio E. Baranzini is Distinguished Professor of Neurology I at the University of California San
Francisco (UCSF). He is also a member of the Graduate Program in Bioinformatics, the Institute for
Human Genetics, the Bakar Computational Health Sciences Institute, ImmunoX, and the California
Institute for Quantitative Biology (QB3). He holds the Heidrich Friends and Family endowed chair in
Neurology. Dr. Baranzini earned his degrees in clinical biochemistry (1992) and PhD in human molecular
genetics (1997) from the University of Buenos Aires, Argentina. Dr. Baranzini then moved to UCSF to
specialize in the analysis of complex hereditary diseases, and focused his efforts on multiple sclerosis. His
current research involves the large throughput analysis of samples from MS patients to characterize the
activity of genes during different stages of the disease, differential response to treatment, and disease
progression. In addition, Dr. Baranzini collaborates with several interdisciplinary teams worldwide to
integrate all the available knowledge obtained in different research domains in an approach known as
systems biology. Dr Baranzini’s current research also involves immunological studies using the EAE
model, sequencing of whole genomes and transcriptomes from patients with multiple sclerosis and
developing bioinformatics tools to integrate this information with that coming from other high throughput
technologies. He also leads the iMSMS, an international consortium to study the effect of bacterial
populations (microbiota) on MS susceptibility and progression.
Dr. Baranzini has published his research on MS in several top-tier journals like Science, Nature, PNAS, J
Immunol, and PLoS Biol. He is a member of the International Multiple Sclerosis Genetics Consortium,
the American Association of Immunologists, and an elected member of the American Neurological
Association and the International Society of Neuroimmunology. He is also a member of the Editorial
Board of the MS Journal, Neurology and mSystems in addition to serving as an ad-hoc reviewer for
several other scientific publications in including Nature Medicine, PNAS, and the Am J Hum Genet.